Seminars

Seminars organized by IBT in the period 2023/2024

  • Seminars are held in the BIOCEV conference hall (U2. 012) from 3:00 p.m.
  • The topics of individual lectures will be updated continuously.
Date Institute Name Topic
12. 10. 2023 IBT Pavel Abaffy Opening new horizons: Single-cell transcriptomic profiling using novel technologies
2. 11. 2023 IBT Joanna Mierzwicka Myomedin-derived binding proteins as novel diagnostic tools for monitoring of PD-1/PD-L1 cell populations in samples of Non-Small Cell Lung Cancer (NSCLC) patients
16. 11. 2023 IMG Allan Akandwanaho Converting molecular-scale torques to embryonic left-right asymmetry
30. 11. 2023 IBT Jan Dohnálek A passion for 3D structure - Mechanistic insights into the role of protein HelD in bacterial RNA polymerase recycling and antibiotic resistance
30. 11. 2023 PřF UK Madiha Kanwal Breaking barriers: unraveling the intricate effect of aspartate b-hydroxylase inhibition on cancer cell behavior
25. 1. 2024 IBT Bohdan Schneider

When will RNA get its AlphaFold moment?

25. 1. 2024 1. LF UK Karel Smetana

Cancer-associated fibroblasts and their role in cancer

8. 2. 2024 IBT Sukanya Balkrishna Jadhav Mitochondrial iron chelation as an anticancer therapy: The role of the NDRG1 tumor suppressor
8. 2. 2024 1. LF UK Lucia Csergeová Identification of novel pathways regulating transition between proliferation and quiescence of breast cancer cells
22. 2. 2024 IBT Jaromír Novák Horizontal mitochondrial transfer in the tumor microenvironment and the role of Miro1
7. 3. 2024 IBT Jiří Černý Structural Bioinformatics of Nucleic Acids: The Sleeper Must Awaken
7. 3. 2024 1. LF UK Jiří Zahradník How to resolve fuzzy complex with protein engineering
21. 3. 2024 IBT Ondřej Šanovec No Swimming, No Life: New Insights into Sperm Immotility
4. 4. 2024 IBT

CMS

Jan Stránský

Jiří Pavlíček

SAXS and SONICC: Two techniques helping in Structural Biology
4. 4. 2024 IEM Nataliya Romanyuk The role of miRNAs in spinal cord injury: A novel therapeutic approach or diagnostic criterion?
18. 4. 2024 IBT Zora Nováková Engineering of antibody-based theranostic molecules targeted to prostate cancer
18. 4. 2024 IPHG Karolína Honzejková

Unraveling the architecture of ASK1: insight into TRX1-mediated regulation

2. 5. 2024 PřF UK Pavel Doležal  
16. 5. 2024 IBT Kateřina Rohlenová  
16. 5. 2024 IPHG Yuriy Petrenko  
30. 5. 2024 IBT Gabriela Pavlínková  
30. 5. 2024 IBT Gustavo Vives Fuertes  
13. 6. 2024 IBT Zdeněk Lánský  
13. 6. 2024 PřF UK Daniel Rozbeský  
27. 6. 2024 IBT Eva Rohlová  
27. 6. 2024 PřF UK O. Součková, P. Žáček